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DURING the last two years of the Great War your president and I had to make our
way to work every day through wards crowded with wounded men, the great
majority of them suffering from a streptococcus infection of their wounds. And in
1918 in those same wards we saw dozens of men die from the deadly streptococcus
pneumonia that so frequently followed influenza dutring the epidemic.
The end of the war came, and we had not got very far with the problem of
controlling these infections. Sir Almroth Wright had shown that they were so
common and so deadly because the streptococcus was able to propagate more freely
in human blood and wound-exudates than any other microbe, but we had learned
very little more than that. Nor for some years was there any very important
advance. Recently things have happened, and I count it a great honour to have
been asked by the trustees of the Robert Campbell Memorial Fund to tell you
something about these recent happenings.
It is a story that would have given great pleasure to Mr. Campbell. He was a
progressive surgeon who started his professional career just at the time when
surgeons were beginning to realize the importance of aseptic technique. That was
a great triumph, but Robert Campbell must often have felt that it was a very
incomplete triumph. Too often he must have been unable to do the operation he
wished to do because the wound was infected. Very often he must have stood by a
patient's bedside and watched the streptococcus take charge, he himself being
unable to do anything to check it.
Let us first consider the astonishing variety and the importance of these infections
by haemolytic streptococci. I can touch upon only a few points-and very briefly.
Puerperal infections by this microbe account for something like 1,20t deaths every
year in England and Wales alone; and for every death there are four or five non-
fatal illnesses. Apart from their importance to the race, these deaths are peculiarly
tragic,. occurring as they do so often just at the crowning moment of a young
woman's life, when her first child is born.
The part played by this streptococcus in connection with war wounds has never,
I think, been fully realized. Every large hospital became a hotbed of streptococcus
infection, with the- result that something like ninety per cent. of wounds which
were not sewn up immediately became infected, and the number of deaths attri-
butable to this complication must have been enormous. Even in the surgery of civil
life, in- spite of modern aseptic technique, the threat of sepsis is by no means
eliminated. A few years ago one of our most distinguished surgeons went through
the records of all the 'clean' operations performed in his own hospital. He found
that no less than two per cent. of such operations were followed by sepsis-a figure
very near that for the incidence of infection by haemolytic streptococci in maternity
work. In many ear, nose, and throat hospitals especially, the frequent occurrence
of streptococcal sepsis and of scarlet fever is, I understand, causing much concern.
And in this connection I need hardly remind you that a very large proportion ofthe deafness of children (and the retarded development so often resultibig from it)
can be traced back to otitis media and mastoid infections by the hemolytic strepto-
coccus, and these in turn usually to a throat infection by that microbe.
Similar throat infections seem to play some part (the nature of which is not yet
clear) in the etiology of rheumatic fever. If that is confirmed, and if the throat
infections can be controlled, we may be able to eliminate much of the crippling heart
disease of children and young adults.
I have said nothing about septicaemia, erysipelas, whitlow,. cellulitis, but you
will agree, I think, that this inventory of evils attributable to infection by* the
haemolytic streptococcus places that microbe quite in the front rank of the enemies
of the human race.
Recognition of the part played by this microbe in all these different pathological
conditions has come very 'slowly; indeed, it is by no means common knowledge yet.
Perhaps we bacteriologists are chiefly to blame for that, because we have been very
slow to learn about the microbe itself. The association of a streptococcus with
suppurative processes was described-and the microbe named-so long ago as
1884, by Rosenbach-and the relationship vigorously championed by Pasteur-
but very little prograss was made towards a satisfactory differentiation of this from
other streptococci for twenty years. In 1903 Schottmuller,l a German physician,
made an important contribution when he reported that by incorporating blood in
his nutrient medium he was able to distinguish the streptococci associated with
acute septic processes, such as cellulitis and erysipelas, from others, by the zone
of hemolysis which developed round their colonies. Unfortunately, very little
attention was paid to this discovery until Howard Brown published his monograph
confirming and amplifying it in 1919.2 Even to-day the "blood-agar plate" which
is so essential for the recognition of the haemolytic streptococci is not used for
routine examinations in the laboratories of some of our largest hospitals.
The recognition of distinct serological types among the strains of hawmolytic
streptococci isolated from human infections (Dochez, Avery, and Lancefield, 1919;3
Griffith, 1935 ;4 and others), and the demonstration by the Dicks5 of the production
of an exotoxin which appears to be responsible for the rash of scarlet fever, were
further advances in our knowledge during the post-war years; but perhaps the
most far-reaching step was that taken in 1933 by Mrs. Lancefield,6 who studied
streptococci from many sources (not only from human infections), and found that
those which form a hemolytic zone round the colony comprise several "groups"
which can be differentiated fairly sharply by serological and biochemical tests.
She further 'showed-and this has been abundantly confirmed-that the great
majority of the strains derived from human septic infections (puerperal fever,
"surgical sepsis," scarlet fever, erysipelas, etc.) belong to one group (A).
THE PREVENTION OF INFECTIONS BY GROUP A HAKMOLYTIC STREPTOCOCCI.
What is the source of the streptococci which cause all these infections, and how
are they transmitted to the patient? On these questions' also we have learned much
4during the past few years. As a student I was taught that septic infection usually
resulted from the transfer of the streptococcus from case to case, by hands, instru-
ments, clothes, etc. I fancy this is still commonly believed; and it may be true as
regards surgical sepsis, because septic cases are, unfortunately, often cared for in
surgical wards along with clean cases. But with modern aseptic and antiseptic
technique,. such transfer from case to case ought not to occur. In maternity work,
I believe, it is quite unusual for infection to be conveyed in that way. Much more
commonly it is due to transfer of the streptococcus from the respiratory tract, and
sometimes probably from infected dust.
The investigation carried out at Queen Charlotte's by my sister Dora Cole-
brooke,7 has brought us as near to proof of this as we are likely to get. She set
out to trace the source of infection in sixty-three cases admitted to Queen Char-
lotte's with puerperal fever (haemolytic streptococcus infection), by taking throat
and nose swabs from all the contacts of these cases, and from the mother herself,
and sometimes also from members of her family. But my sister was not content
with merely isolating haemolytic streptococci from one or other of these contacts.
By a very laborious piece of work she determined whether the suspect strains were
really identical or not with that isolated from the mother's uterus or blood. In this
way she was able to find a "possible or probable" extragenital source of infections
in connection with forty-eight of the sixty-three mothers investigated. In her very
cautious summary she concludes that transfer of the streptococcus had probably
occurred from an "attendant-contact," i.e., doctor or nurse or midwife, in just half
the cases, and, with one exception, always from the throat or nose; while in
nearly twenty per cent. of them the infection had probably come from a member of
the mother's family. In thirteen per cent. it appeared probable that the infection
had travelled from the mother's own throat or nose, most likely by the agency of
her hands.
I referred to the possibility of dust-borne infections. In our single rooms at Queen
Charlotte's it has been quite clearly shown (White8) by exposing blood-agar
plates that the dust in the environment of the patient discharging haemolytic strep-
tococci becomes contaminated by that microbe. A large number of colonies were
sometimes grown on such plates when the air was stirred as by making the bed or
sweeping the floor, whereas none was grown on plates exposed in the wards housing
patients not infected by haemolytic streptococci.
It seems clear, then, that in framing our preventive measures for the future-
for maternity work,. but also medical and surgical work-we have to keep in mind
many possible sources of infection: the respiratory tract (particularly when
inflamed) of doctors and nurses, but also the patient's, and members of his or
her family; dust; transfer from a septic case, etc. Quite possibly there are others
that we do not yet reckon with, for this microbe is very widely distributed.
The ideal preventive measure to meet this difficult situation would be artificial
immunization of the whole community against bemolytic streptococcus (of group A
at any rate), analogous to that which is being attempted in some communities
against diphtheria, but at present this is not in sight. Group A strains comprisemnany distinct types, just as the different race's of mankind comprise distinct families
with -their special characteristics, and immunity to one particular streptococcal
type does not seem to imply immunity to others. So far we have not found any
means of overcoming that difficulty.
What' can be done to prevent dissemination of the dangerous strains? In the
conditions of our modern life-herding together at clo'se quarters in buses, trains,
cinemas, etc.-this is evidently very difficult, but much more could be done than
is being done to prevent the' transfer of such strains in special circumstances. In
maternity and surgical work, for example, where the patients are exposed to special
risks because they have open wounds, much can be done to "trap" the strepto-
coccus at its exit from the respiratory tract of the dangerous carriers by the
intelligent use of efficient masks, and by the strict exclusion from contact with such
patients of all persons who have an infection of the respiratory tract-a "cold,"
tonsillitis,. a sinus infection, etc. And we can do much also to "trap" the strepto-
coccus at its point of entry to the vulnerable tissues of the patient, by more
efficient antisepsis, the use of rubber gloves, the exclusion of infected dust, etc.
To the same end we must, of course, be more vigilant than heretofore'in the
detection of the early cases of haemolytic streptococcus infection, whether in
maternity or surgical work, with a view to their immediate segregation from
other "clean" cases; and in connection with every such case it should become part
of the normal routine to institute an inquiry as to the possible source of the
infection, lest this source may continue to be a danger to other patients. All this
means making much more use of our bacteriological laboratories in the fight against
hemolytic streptococcus infection, just as we are doing in the case of diphtheria
and syphilis. It means also, especially in regard to maternity work, that our admini-
strative services must be much more wideawake to the dangers arising from the
mixing up of clean midwifery cases with infected surgical and medical cases in
small general hospitals and mixed nursing-homes, where there is no possibility of
adequate segregation. May I put it to you individually, gentlemen, that you would
not feel very happy if you knew that your wvife was being confined in the same
institution where there were also mastoid, erysipelas, or tonsillitis cases.The doctors,
nurses, and wardmaids in contact with the latter cases may become throat-carriers,
and transmit the streptococcus to those in charge of the maternitv cases; the dust
will cerainly be infected, and be disseminated by air-currents, boots, etc.; and, owing
to ignorance or insufficient supervision, a nurse may sometimes attend both patients,
especially when the staff is reduced at night. These are not just imaginary happen-
ings. There is good reason to be-ieve that they actually do occur-and not very
infrequently-under our present too-casual arrangements. New Zealand showed
us the way of dealing with this situation several years ago, when it took legislative
steps to prevent the mixing up of maternity and infected cases in institutions which
could not provide complete segregation. That policy has been followed by a remnark-
able decline in puerperal sepsis. Why do we lag behind in safeguarding the mothers?
Much more can be done, too, by prropaganda and more teaching in regard to the
sources of infection, antisepsis, etc.; there is an enormous amount of ignorance tobe overcome. An obstetric friend of mine was called in not long ago to put on
forceps in a-difficult Case. In the middle of the proceedings the nurse in attendance
dropped he-r handkerchief on the perineum. Not wishing to make a scene at the
moment, my friend remonstrated rather mildly. The nurse replied: "Oh, it doesn't
matter, doctor; it was only an old one."
IHE TREATMENT OF HARMOLYTIC STREPTOCOCCUS INFECTIONS BY
PRONTOSIL AND PARA AMINO-BENZENE-SULPHONAMIDE.
May I begin by calling your attention'to the muddle we are getting into by the
multiplication of trade names for these new therapeutic remedies. The term 'pron-
tosil' is now commonly used without any qualifying adjective for three quite distinct
chemical substances, and there are already some sixteen different trade names for
the simple substance para amino-benzene-sulphonamide. This being so, I feel it is
essential for the future to fall into line with ordinary scientific practice as far as
may be,. and avoid all such trade-registered names, using instead a suitable abbrevi-
ation of the 1descriptive chemical term. A special difficulty arises in the case of
prontosil, in that two of the substances to which that name is given are red dye-
stuffs-the one "prontosil red," sparingly soluble, used for oral administration,
and the other "prontosil soluble," much more soluble, for injection. In this com-
munication, however, it will not be,necessary to distinguish between the two, and
I shall therefore refer to the two substances comprehensively as "the red dyes" or
(not quite properly in the case of the soluble compound) as sulphamido-chrysoidine.
For para amino-benzene-sulphonamide I shall use the proper abbreviation
"sulphanilamide."
The discovery of sulphamido-chrysoidine seems to have come about in this way.
Many years ago German chemists found that in order to make aniline dyes fast for
fabrics, they required to have a double nitrogen bond uniting two benzene rings,
and an SO2 NH2 group- (sulphonamide) in the para position on one of the rings.
Somebody later on made the intelligent guess that this same constitution might
confer on these dyes a high destructive affinity for certain microbic protoplasms.
Domagk and his co-workers9 therefore "tried out" -a number of such dyestuffs in
animals which had :been experimentally infected with various pathogenic bacteria.
He found that the red dyestuff sulphamido-chrysoidine, if given to mice by stornach-
tube within an hour Or two after their infection with haemolytic streptococci (intra-
peritoneal), would save most of the animals. Later it was found by Tr6fouel, Nitti,
and BovetlO at the Pasteur Institute that the simpler substance sulphanilamide,
which had only one benzene ring, but still the SO2 NH2 group, would save mice
equally well.
We confirmed these curative effects in animals at Queen Charlotte's, and also
showed that although the -red dyes had practically no power to kill haemolytic
streptococci in blood or in water outside the body (as Domagk had stated), it was
quite otherwise with sulphanilamnide. Unlike the ordinary antiseptic, this substance
conferred a high bactericidal power upon human blood in vitro, but had only a
7feeblereffect in watery solution. The blood of patients under treatment by sulphani-
lamide had a greatly increased bactericidal effect upon haemolytic streptococci after
the first few hours, and, what was more surp-rising, the blood of patients treated by
the red dyes had a similar power-although. it, developed much more slowly,, i.e.,
ten to twenty-four hours after the first dose, The explanation of this latter finding
was provided by my colleague Fuller,11 who showed that a large part of the red
dyes is converted in the body into sulphanilamide, and excreted as such. His work,
and that of Marshall Emerson and Cutting,12 further showed that these substances
are extremely diffusible in the body-even appearing in the cerebro-spinal fluid in
considerable.quantities., It.is probable that they owe much of their remarkable
the;rapeutic effect to this attribute..
We now come to the important questions: Do these.compounds really exert a cura-
tive effect in the naturally occurring infections of man? and if so, how do they act?
It is important to remember that in' the human diseases we have to treat, the
bacteria are well entrenched in the tissues-a very different state of affairs from
that in the experimentally. infected animal. We were in a particularly fortunate
position at Queen Charlotte's for judging the clinical effects of treatment,.. because
for five years before the introduction of the red dyes we had not been giving our
puerperal fever patients any specific treatment., The, death-rate,for all such patients
infected by hamolytic streptococci had continued high,., the average being 22.8
per cent. During 1935 it-had actually been-twenty-four per cent. Since the beginning
of 1936, when we began to use the red dyes, the death-rate for all the two hundred
cases thus infected (with no exceptions at all) has dropped to 5,5 per cent. Along
with this remarkable fall there has. been a complete change in the clinical picture.
The temperature charts show it best. Almost with regularity the fever comes down
to normal within one to fo.ur days from the commencement of treatment, and it
usually remains down. The stay in hospital has been reduced.from an average of
thirty-one days to one of nineteen days. And the troublesome cases of parametritis
that we used to see have practically disappeared. Is.all this due.to the treatment, or
is it due to a coincident and sudden change in the disease process? Scarlet fever
formerly had a high mortality in Belfast and elsewhere, and is now a very mild
disease. But that change has happened gradually. There is some evidence that
puerperal infections have become milder of late, but it is very difficult to be sure of
it. Certainly fewer cases are developing the more grave complications such as
peritonitis. and septicaemia during the last two years, but that is precisely what
would happen if we had an effective remedy.
My colleague Dr. Fry recently sorted out all the cases which had had a positive
blood-culture (haemolytic streptococcus) during the past six years, regarding these
as cases in which there was definite evidence that the streptococcal strain had an
"invasive" character. .He* found. that whereas during the four years before
sulphamido'.chrysoidine was introduced (eighty-eight in number), these cases had
a mortality-rate of seventy..one per cent., those for the last two;years (twenty-two
cases) had a mortality-rate of only twenty-seven per cent.-That seems to.me to
indicate that.even in "invasive" cases the drugs have had a very definite.effect.
8I feel that in trying to arrive at a decision on this important question, we ought
to take into account all the available evidence bearing upon it-'not only' the
evidence from our puerperal fever cases, We ought to take into account that animals
are certainly cured; that the blood of humfia'n patients acquires a remarkable
increase in its power to kill haemolytic streptococci; and also the fact that recoveries
are now being.reported quite frequently under circumstances which make-it almost
impossible to doubt a favourable action of the drug. Particularly. valuable from
this last point of view are the results obtained within the last eighteen months in
streptococcal meningitis. As you know, this infection has always carried a death-
rate of well over-ninety per cent, A recent survey put it at ninety-seven per cent.
(Grayl5). In the past few months no less than twenty-five recoveries. have been
reported after treatment by sulphamido-chrysoidine or sulphanilamide.
Let us by all means keep an open mind and.a critical attitude in adjudicating, upon
clinical events. With regard to our puerperal fever results, I conclude that while a
diminished severity of the disease may have played some -part in the. improvement
in results, I feel it is highly probable that the largest part of that improvement has
been due to the drug treatment.
I will pass now to speak very briefly of two or three practical points that emerge
from our experience with these compounds.
First, as to the relative value of sulphanilamide and of the red dyes. We have
treated the last 115 cases with Streptocide,. a preparation of sulphanilamide supplied
by Messrs. Evans, Sons, Lescher & Webb to. the Therapeutic Trials Committee of
the Medical Research Council for clinical trial, and have tried to compare the
results obtained with those we got.from the first sixty-four cases treated by the red
dyes during 1936. The comparison has been reported fully in the "Lancet" of 27th
November and 4th December, 1937. Broadly speaking,.the results were similar,
but we felt that those obtained with the red dyes, notwithstanding a rather lower
scale of dosage, were slightly more impressive than those obtained with Streptocide.
I do not wish to stress this conclusion, as it is manifestly impossible to assess
clinical results with accuracy. Fortuitous circumstances may have contributed to
the results; the dosage of sulphanilamide may not have been optimal, and it is
quite possible that further experience will show that there is no real differ-ence.
Secondly, as regards dosage of sulphanilamide'.' It is too early to dogmatize on
this question, and we have little to guide'us at present'except accumulated clinical
experience. The dosage of the red dyes was described in the "Lancet" a year ago
(December 6, 1936), and of sulphanilamide in the more recnt papers just referted
to. Four to six grammes.-daily during the febrile-period, falling to three grammes
as the temperature drops,,has appeared to give us satisfactory results in most cases.
It is advisable to continue the drug for a few days after the temperature is normal,
but not longer than ten to fourteen days as-a rule.
Thirdly, I would emphasize that we have seen no good results so far in puerperal
infections caused by microbes other than the haemolytic streptococcus (I am
excluding the urinary infections by B. coli in the puerperium-in these we have
obtained very satisfactory results). It not unfrequently happens now that a patient
9is admitted on account of continuing fever, who has been having treatment by
sulphanilamide or the red dyes for a week or more. We find she has no infection by
haemolytic streptococci, and stop the drug, with the result that the temperature
immediately settles down to normal. I shall refer to this again in a moment.
Finally, I will tell'you what toxic effects we have experienced with these drugs.
By far the most conspicuous has been cyanosis. More than fifty per cent. of the
cases treated by sulphanilamide have shown some degree, usually slight, of leaden
blueness of the lips and finger-nails. It is uncertain how often this occurs with the
red dyes-we noticed it only on three occasions, but I suspect that we may have
missed it fairly often. Cyanosis has usually been associated with the presence of
met- or sulph-haemoglobin in the blood, but in the great majority of patients this
change seems to have done no harm. In three cases it was accompanied by profound
exhaustion, but we could not be sure how far the two conditions were related, nor
how far the patient's infection was responsible for the exhaustion. Headache has
occurred in some cases, and also depression, while a few have complained of "spots
before the eyes," a slight dimness of vision, tingling or numbness of the extremi-
ties, but in no cases have these effects been severe.
Perhaps the most interesting observation, apart from cyanosis, has been what
American writers have called "drug fever." In sorme six or seven patients, a little
while after the fall of the temperature to normal, it began to rise again while the
drug was still being given. There were no signs of a recrudescence of the infection
-convalescence was proceeding normally-and on discontinuing the- drug the
temperature quickly fell. Rather more often there has been a recurrence of fever a
few days after stopping the drug. In these cases there may have been a slight
"sub-perceptible" recrudescence of the infection; at any rate, the fever quickly
subsided on restarting the drug.
It seems clear, then, that patients taking these drugs ought to be under careful
supervision, and that indiscriminiate prescription of them for all sorts of conditions
is not warranted, either by clinical experience or by scientific observation.
That brings me to speak for a moment about their employment for the prevention
of infection by haemolytic streptococci. Experiments with mice certainly suggest
that by giving a dose a few hours before an infection occurs, and once or twice a
day for three or four days after, we can altogether prevent the development of the
fatal infection, and, as I told you, we can demonstrate a greatly increased killing
power in the blood of patients taking these compounds.
It does seem possible, therefore-indeed, I-think probable, that they will prove
to have some usefulness as prophylactic agents, but here again they should be used
with discretion, particularly in maternity work. There are frequent occasions when
a woman is known or suspected to be exposed to special risk of a henmolytic
streptococcus infection-for example, when there is an outbreak of sepsis in a
maternity institution, or when she herself has a tonsillitis or an infected wound or
erysipelas, or again, when a member of her family has a similar possible source of
infection; in such special circumstances it seems to me quite legitimate and wise to
l0give the mother fifteen grains of sulphanilamide two or three times daily for four
days (not longer) from the beginning of labour. It should not be given as a routine
before labour.
Possibly also such prophylactic treatment may find useful application in con-
nection with tonsil operations, but in this case it would be well to bear in mind the
transient cyanosis induced by the anesthetic.
A more lasting immunity will probably never be achieved by the drugs, but it may
be obtained some day by means of vaccine therapy. At present it is not in sight,
because the strains of streptococci included in group A are themselves divided into
many different types, and immunity to one does not imply immunity to all.
In conclusion, I would say that we seem to have got a new weapon in our hands
which is going to prove very valuable. It will, however, sometimes fail. Let us
make haste slowly. Let us find out when it should be used, what harm it may do-
above all, how it works. When that is known, it may prove to be the biggest
advance in medical knowledge for many years.
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